Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity.

Laura de Armas-RilloJuan C Quevedo-AbeledoAntonia de Vera-GonzálezAlejandra González-DelgadoJosé A García-DopicoAlejandro Jimenez-SosaCarlos Rodríguez-LozanoMiguel A González-GayIván Ferraz-Amaro

Published in: Rheumatology (Oxford, England) (2021)

PCSK9 is downregulated in patients with axSpA. Disease activity is positive and significantly related to PSCK9. Anti-TNF-therapy yields a reduction in PCSK9 serum levels.

Keyphrases

disease activity
low density lipoprotein
rheumatoid arthritis
systemic lupus erythematosus
ankylosing spondylitis
rheumatoid arthritis patients
juvenile idiopathic arthritis
stem cells
cell therapy
mesenchymal stem cells